Key result
Long-acting nitroglycerin formulations, including intravenous, transdermal, and transmucosal options, offer a new era of rational and effective prophylaxis for angina.
Design
Editorial
Authors
Loading...
An editorial discussing the advent of long-acting nitroglycerin formulations for the prophylaxis of angina.
An editorial discussing the advent of long-acting nitroglycerin formulations for the prophylaxis of angina.
Nathaniel Reichek (1982) conducted an editorial in Angina. Long-acting nitroglycerin was evaluated. Long-acting nitroglycerin formulations, including intravenous, transdermal, and transmucosal options, offer a new era of rational and effective prophylaxis for angina.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: